ACNM/SNMMI Webinar Series: Fluciclovine PET/CT for Prostate Cancer: Applications CE/SAM

MOC Part II SAM Modules

ACNM/SNMMI Webinar Series Fluciclovine (Axumin) PET/CT for Prostate Cancer: Applications (CE/SAM)

Release Date:03/15/2022 Expiration Date: 03/31/2025

Physician member - Free
Physician non-member - $49.00

Continuing Education Credit Information

The American Board of Nuclear Medicine has reviewed and approved this Journal SAM activity submitted by the SNMMI. This activity fulfills the requirements of the ABNM Maintenance of Certification program for self-assessment. 1.0 SAMs have been awarded for this activity.

AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SNMMI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

At the completion of this activity, the participant will be able to:
1. Discuss the basic mechanism of Fluciclovine PET
2. Discuss appropriate clinical indications for Fluciclovine PET
3. Improve interpretation of Fluciclovine PET

Target Audience
The Life Long Learning and Self-Assessment activity is designed for all nuclear medicine physicians and radiologists.




Gary Ulaner, MD, PhD, FACNM


ACNM President-Elect

Hoag Cancer Center

Consultant, Research Grant and Speaker’s Bureau for Lantheus, GE Healthcare, and ImaginAb

Katherine Zukotynski, BASc, MD, PhD, P.Eng


ACNM Vice President-Elect

McMaster University

Nothing to Disclose

Twyla Bartel, DO, FACNM, FSNMMI


ACNM Education Committee Co-Chairperson

Global Advanced Imaging, PLLC

Nothing to Disclose

Gbenga A. Shogbesan, MD


Emory University

Nothing to Disclose

Jonathan McConathy, MD, PhD


University of Alabama, Birmingham

Consultant - Blue Earth Diagnostics; Eli Lilly/Avid; ImaginAB; GE Healthcare; Canon Medical

Research Grant - Blue Earth Diagnostics; Eli Lilly/Avid; ImaginAB; Cytosite Biopharma

The ACNM Education Committee, reviewers and SNMMI Staff have indicated that they do not have a financial interest, arrangement or affiliation with any commercial organization that may have a direct or indirect interest in the content presented.

Mark Tulchinsky, MD, FACNM, FSNMMI

ACNM President

Penn State Health, Milton S. Hershey Med. Center

Perry Gerard, MD, MBA

No affiliation

ACNM Education Committee Co-Chair

Tracy L. Yarbrough, MD, PhD, MAEd, FACNM

California Northstate University

ACNM Education Committee Co-Chair

Ragheed Al-Dulaimi, MD, MPH, MSc

Hurley Medical Center

ACNM Education Committee Member

Ishani Dalal, MD

Henry Ford Hospital

ACNM Education Committee Member

Joseph S. Fotos, MD

Penn State Milton S. Hershey Medical Center

ACNM Education Committee Member

Erin Grady, MD, CCD, FACNM

Emory University School of Medicine

ACNM Education Committee Member

Erica J. Cohen Major, DO, MPH, FACNM

Edward Hines VA

ACNM Education Committee Member

Carl I. Odom, MD, MS

Austin Radiological Association

ACNM Education Committee Member

Guofan Xu, MD, PhD

The University of Texas MD Anderson Cancer Center

ACNM Education Committee Member

Arnold M. Strashun, MD

Chair, Continuing Education Committee

Helen Nadel, MD

CE Reviewer

Caroline Krystek

SNMMI Staff, Education

No Commercial Support was received for this activity

Financial Disclosures
In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the speaker has indicated no relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.

Contact Information
For questions please contact Lisa Dickinson, Associate Director of Education at or 703-652-6783.